Nephros (NEPH) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Nephros (NEPH) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 25.17% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -2.06% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 81.56% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 2.65% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 10.16% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.69% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -13.46% |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | -5.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.39% |
| Mar 31, 2026 | -3.89% |
| Dec 31, 2025 | -2.96% |
| Sep 30, 2025 | -2.40% |
| Jun 30, 2025 | -33.72% |
| Mar 31, 2025 | -28.05% |
| Dec 31, 2024 | 30.77% |
| Sep 30, 2024 | -23.21% |
| Jun 30, 2024 | -15.01% |
| Mar 31, 2024 | -23.00% |
| Dec 31, 2023 | -19.83% |
| Sep 30, 2023 | -33.70% |
| Jun 30, 2023 | -30.82% |
| Mar 31, 2023 | 12.08% |
| Dec 31, 2022 | 12.72% |
| Sep 30, 2022 | 14.62% |
| Jun 30, 2022 | 71.64% |
| Mar 31, 2022 | 58.19% |
| Dec 31, 2021 | -7.51% |
| Sep 30, 2021 | 167.31% |